66 related articles for article (PubMed ID: 8901150)
1. Effects of furosemide, torasemide and controlled fluid intake on perfluoroisobutene induced lung oedema and mortality.
Onyefuru LC; Upshall DG; Rice P
Arzneimittelforschung; 1996 Mar; 46(3):283-7. PubMed ID: 8901150
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacodynamics of torasemide and furosemide in patients with oedema.
Herchuelz A; Deger F; Douchamps J; Ducarne H; Broekhuysen J
Arzneimittelforschung; 1988 Jan; 38(1A):180-3. PubMed ID: 3285831
[TBL] [Abstract][Full Text] [Related]
3. Protection of rats against perfluoroisobutene (PFIB)-induced pulmonary edema by curosurf and N-acetylcysteine.
van Helden HP; van de Meent D; Oostdijk JP; Joosen MJ; van Esch JH; Hammer AH; Diemel RV
Inhal Toxicol; 2004 Jul; 16(8):549-64. PubMed ID: 15204746
[TBL] [Abstract][Full Text] [Related]
4. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
[TBL] [Abstract][Full Text] [Related]
5. Exercise potentiation of lung injury following inhalation of a pneumoedematogenic gas: perfluoroisobutylene.
Lehnert BE; Archuleta D; Gurley LR; Session W; Behr MJ; Lehnert NM; Stavert DM
Exp Lung Res; 1995; 21(2):331-50. PubMed ID: 7774531
[TBL] [Abstract][Full Text] [Related]
6. Effect of inhaled furosemide and torasemide on bronchial response to ultrasonically nebulized distilled water in asthmatic subjects.
Foresi A; Pelucchi A; Mastropasqua B; Cavigioli G; Carlesi RM; Marazzini L
Am Rev Respir Dis; 1992 Aug; 146(2):364-8. PubMed ID: 1489126
[TBL] [Abstract][Full Text] [Related]
7. The effect of perfluoroisobutene and phosgene on rat lavage fluid surfactant phospholipids.
Jugg B; Jenner J; Rice P
Hum Exp Toxicol; 1999 Nov; 18(11):659-68. PubMed ID: 10602390
[TBL] [Abstract][Full Text] [Related]
8. Oral N-acetylcysteine protects against perfluoroisobutene toxicity in rats.
Lailey AF
Hum Exp Toxicol; 1997 Apr; 16(4):212-6. PubMed ID: 9154446
[TBL] [Abstract][Full Text] [Related]
9. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
Brunner G; von Bergmann K; Häcker W; von Möllendorff E
Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of torasemide and furosemide in liver cirrhosis.
Fiaccadori F; Pasetti GC; Pedretti G; Pizzaferri P; Elia GF
Cardiology; 1994; 84 Suppl 2():80-6. PubMed ID: 7954549
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.
Laffi G; Marra F; Buzzelli G; Azzena G; Meacci E; De Feo ML; La Villa G; Gentilini P
Hepatology; 1991 Jun; 13(6):1101-5. PubMed ID: 2050329
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
Kult J; Häcker W; Glocke M
Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
[TBL] [Abstract][Full Text] [Related]
13. The prophylactic and therapeutic effects of cholinolytics on perfluoroisobutylene inhalation induced acute lung injury.
Zhang T; Zhang X; Shao Z; Ding R; Yang S; Ruan J; Sun X; Xu J; Huang C; Hu Z; Zhang X
J Occup Health; 2005 Jul; 47(4):277-85. PubMed ID: 16096351
[TBL] [Abstract][Full Text] [Related]
14. Protection by cysteine esters against chemically induced pulmonary oedema.
Lailey AF; Hill L; Lawston IW; Stanton D; Upshall DG
Biochem Pharmacol; 1991 Dec; 42 Suppl():S47-54. PubMed ID: 1768285
[TBL] [Abstract][Full Text] [Related]
15. Electron microscopy of rat lung following a single acute exposure to perfluoroisobutylene (PFIB). A sequential study of the first 24 hours following exposure.
Brown RF; Rice P
Int J Exp Pathol; 1991 Aug; 72(4):437-50. PubMed ID: 1883743
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure.
Mourad G; Haecker W; Mion C
Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
Stroobandt R; Dodion L; Kesteloot H
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):151-8. PubMed ID: 6762167
[TBL] [Abstract][Full Text] [Related]
18. Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint.
Spannheimer A; Goertz A; Dreckmann-Behrendt B
Int J Clin Pract; 1998 Oct; 52(7):467-71. PubMed ID: 10622087
[TBL] [Abstract][Full Text] [Related]
19. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
Klütsch K; Grosswendt J; Haecker W
Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
[TBL] [Abstract][Full Text] [Related]
20. Treatment of vasogenic brain edema with the novel Cl- transport inhibitor torasemide.
Staub F; Stoffel M; Berger S; Eriskat J; Baethmann A
J Neurotrauma; 1994 Dec; 11(6):679-90. PubMed ID: 7723067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]